326 results on '"HAYASHI H"'
Search Results
2. A phase II trial of paclitaxel plus biweekly cetuximab for patients with recurrent or metastatic head and neck cancer previously treated with both platinum-based chemotherapy and anti-PD-1 antibody
3. Translational insights and overall survival in the U31402-A-U102 study of patritumab deruxtecan (HER3-DXd) in EGFR-mutated NSCLC
4. Electrochemical recovery of Zr and Cd from molten chloride salts for reprocessing of used nitride fuels
5. Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial
6. 1279P First-line lorlatinib vs crizotinib in Asian patients with ALK+ non-small cell lung cancer (NSCLC): 5-year outcomes from the CROWN study
7. Corrigendum to ‘A phase II trial of paclitaxel plus biweekly cetuximab for patients with recurrent or metastatic head and neck cancer previously treated with both platinum-based chemotherapy and anti-PD-1 antibody’: [ESMO Open volume 9 issue 6 (2024) 103476]
8. Integrated radiation monitoring and interlock system for the LHD deuterium experiments
9. Local heating induced by single MeV C60 ion impacts
10. Temperature of thermal spikes induced by swift heavy ions
11. Micro structure processing on plastics by accelerated hydrogen molecular ions
12. The relationship between polypharmacy and recovery of activities of daily living among convalescent stroke patients: A propensity score-matched analysis
13. Evaluation of local temperature around the impact points of fast ions
14. Comparison of rate-dependent constitutive models with experimental data
15. Half-life Measurements of Excited Levels in Fission Products around Mass Number 150
16. Measurements of High-energy Excited States and γ-rays of Fission Products with a 4π Clover Detector
17. Performance of a total absorption clover detector for Qβ measurements of neutron-rich nuclei far from the β-stability line
18. MA12.07 Amivantamab Plus Lazertinib vs Osimertinib in First-Line, EGFR-Mutant Advanced NSCLC: Patient-relevant Outcomes from MARIPOSA
19. MA12.06 PAPILLON: TP53 Co-mutations, Sites of Insertion, and ctDNA Clearance Among Patients with EGFR Ex20ins-Mutated Advanced NSCLC
20. OA02.03 Amivantamab Plus Lazertinib vs Osimertinib in First-line EGFR-mutant Advanced NSCLC: Longer Follow-up of the MARIPOSA Study
21. OA04.03 Ifinatamab Deruxtecan (I-DXd) in Extensive-Stage Small Cell Lung Cancer (ES-SCLC): Interim Analysis of Ideate-lung01
22. PL04.07 FURTHER: A Global, Randomized Study of Firmonertinib at Two Dose Levels in TKI-Naive, Advanced NSCLC with EGFR PACC Mutations
23. OA02.05 Lazertinib vs Osimertinib in 1L EGFR-Mutant Advanced NSCLC: A Randomized, Double-Blind, Exploratory Analysis from MARIPOSA
24. LBA55 Mechanisms of acquired resistance to first-line amivantamab plus lazertinib versus osimertinib in patients with EGFR-mutant advanced non-small cell lung cancer: An early analysis from the phase III MARIPOSA study
25. LBA52 Interim analysis of GALAXIES Lung-201: Phase II, randomized, open-label platform study of belrestotug plus dostarlimab in patients (pts) with previously untreated locally advanced/metastatic (LA/M) PD-L1 high (TPS >/=50%) non-small cell lung cancer (NSCLC)
26. 225P Nivolumab for cancer of unknown primary (CUP): Clinical efficacy and biomarker analysis from NivoCUP2 expanded access program (WJOG14620M)
27. 690TiP HERTHENA-PanTumor01: A global phase II trial of HER3-DXd in metastatic solid tumors
28. 1812TiP IDeate-Lung03: A Phase Ib/II study of ifinatamab deruxtecan (I-DXd) plus atezolizumab (atezo) with or without carboplatin (carbo) as first-line (1L) induction or maintenance in patients (pts) with extensive stage (ES) small cell lung cancer (SCLC)
29. 1357P Multicenter phase II study of cisplatin and gemcitabine plus necitumumab in patients with unresectable, advanced lung squamous cell carcinoma who have progressed on or after initial treatment with immune checkpoint inhibitors plus platinum-based chemotherapy: WJOG14120L NESSIE study
30. 1312P Datopotamab deruxtecan (Dato-DXd) vs docetaxel (DTX) in patients (pts) with advanced nonsquamous (NSQ) non-small cell lung cancer (NSCLC) with brain metastases (mets): Results from TROPION-Lung01
31. 621P Phase II trial of encorafenib and binimetinib (E+B) in patients (pts) with BRAF-altered advanced solid tumors: Results of E+B cohort in the BELIEVE trial (NCCH1901)
32. Spin-aligned RI beams via two-step fragmentation reactions
33. Stability of precipitates in ZIRLO under high energy particle irradiation
34. Preparation and characterization of epitaxial growth of ZnO nanotip arrays by hydrothermal method
35. The short-circuit test results of 6.9 kV/2.3 kV 400 kVA-class YBCO model transformer with fault current limiting function
36. (958) - Impact of Preoperative Left Ventricular Ejection Fraction on Outcomes After Pulmonary Thromboendarterectomy for Chronic Thromboembolic Pulmonary Hypertension
37. (836) - Mechanism and Clinical Impact of Late Tricuspid Regurgitation in Patients with Heartmate 3
38. Magnetic separation technique for groundwater by five HTS melt-processed bulk magnets arranged in a line
39. The short-circuit test results of 6.9 kV/2.3 kV 400 kVA-class YBCO model transformer
40. AC over-current test results of YBCO conductor for YBCO power transformer with fault current limiting function
41. Frequency characteristics of a nuclear spin maser for the search for the electric dipole moment of 129Xe atom
42. Preparation and characterization of nanocrystalline ITO thin films on glass and clay substrates by ion-beam sputter deposition method
43. Evaluation of erosion resistance for metal–ceramic composites and cermets using a water-jet testing apparatus
44. P144 - MANDIBULAR BODY OSTECTOMY FOR CORRECTION OF MANDIBULAR PROGNATHISM: REPORT OF 6 CASES
45. Development of YBCO power devices in Japan
46. Developments of SOI monolithic pixel detectors
47. Dynamic nuclear polarization of 29Si via spin S=1 centers in isotopically controlled silicon
48. Development of 1 kA class HTS coil for superconducting power transformers
49. Development of REBCO superconducting power transformers in Japan
50. Japanese efforts on coated conductor processing and its power applications: New 5 year project for materials and power applications of coated conductors (M-PACC)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.